Telmisartan Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Telmisartan Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for therapy of hypertension, in cardiac arrest, and in stroke management. Telmisartan was approved for use in the U.S., for treatment of hypertension in 1998. Telmisartan is available in 20, 40 and 80 mg tablets in generic forms and under the trade name, Micardis. The typical dose of Telmisartan in adults is 40 to 80 mg once daily, and it is used long term. Telmisartan is also available in fixed combinations with hydrochlorothiazide, and amlodipine.

Market Dynamics

Prevalence of high blood pressures, is increasing globally attributed to rising geriatric population, chronic disorders such as diabetes, and changing lifestyles which in turn is expected to increase the demand for telmisartan in global market. According to Blood Pressure UK, 2017 update, high blood pressure is the leading cause of heart disease and stroke, killing around 7.5 million people worldwide every year. In 1975, 594 million people were suffering from high blood pressure which increased to 1.1 billion in 2015 and is thought to be due to population growth and an aging population. Thus, rise in geriatric population suffering from high blood pressure is expected to be major factor for growth of telmisartan market in the forecast period.

Furthermore, increasing approvals for Abbreviated new Drug Application (ANDA) for manufacturing of generic telmisartan tablets is propelling growth of telmisartan in the global market. For instance, in July 2014, Glenmark Generics Inc., USA—a subsidiary of Glenmark Generics Limited—received ANDA approval from the U.S. Food and Drug Administration (USFDA) for telmisartan tablets.

Key features of the study:

  • This report provides in-depth analysis of the telmisartan market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global telmisartan market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include C.H. Boehringer Sohn AG & Ko. KG, Glenmark Generics Inc., Torrent Pharmaceuticals Ltd., Solco Healthcare U.S., Mylan Inc., Aurobindo Pharma Limited, Yichang Changjiang Pharmaceutical Co., Ltd, Wanbang Biopharmaceuticals, and Nippon Boehringer Ingelheim Co., Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global telmisartan market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for telmisartan market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Global Telmisartan Market, By Strength:
  • 20mg
  • 40mg
  • 80mg
  • Global Telmisartan Market, By Indication:
  • Hypertension
  • Cardiac Arrest
  • Stroke
  • Global Telmisartan Market, By Composition:
  • Single
  • Combinational
  • Global Telmisartan Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Telmisartan Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • Global Telmisartan Market, By Strength:
  • 20mg
  • 40mg
  • 80mg
  • Global Telmisartan Market, By Indication:
  • Hypertension
  • Cardiac Arrest
  • Stroke
  • Global Telmisartan Market, By Composition:
  • Single
  • Combinational
  • Global Telmisartan Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Global Telmisartan Market, By Strength:
  • 20mg
  • 40mg
  • 80mg
  • Global Telmisartan Market, By Indication:
  • Hypertension
  • Cardiac Arrest
  • Stroke
  • Global Telmisartan Market, By Composition:
  • Single
  • Combinational
  • Global Telmisartan Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Global Telmisartan Market, By Strength:
  • 20mg
  • 40mg
  • 80mg
  • Global Telmisartan Market, By Indication:
  • Hypertension
  • Cardiac Arrest
  • Stroke
  • Global Telmisartan Market, By Composition:
  • Single
  • Combinational
  • Global Telmisartan Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Global Telmisartan Market, By Strength:
  • 20mg
  • 40mg
  • 80mg
  • Global Telmisartan Market, By Indication:
  • Hypertension
  • Cardiac Arrest
  • Stroke
  • Global Telmisartan Market, By Composition:
  • Single
  • Combinational
  • Global Telmisartan Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Global Telmisartan Market, By Strength:
  • 20mg
  • 40mg
  • 80mg
  • Global Telmisartan Market, By Indication:
  • Hypertension
  • Cardiac Arrest
  • Stroke
  • Global Telmisartan Market, By Composition:
  • Single
  • Combinational
  • Global Telmisartan Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Global Telmisartan Market, By Strength:
  • 20mg
  • 40mg
  • 80mg
  • Global Telmisartan Market, By Indication:
  • Hypertension
  • Cardiac Arrest
  • Stroke
  • Global Telmisartan Market, By Composition:
  • Single
  • Combinational
  • Global Telmisartan Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Company Profiles
  • C.H. Boehringer Sohn AG & Ko. KG *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Glenmark Generics Inc.
  • Torrent Pharmaceuticals Ltd.
  • Solco Healthcare U.S.
  • Aurobindo Pharma Limited
  • Mylan Inc.
  • Yichang Changjiang Pharmaceutical Co., Ltd
  • Wanbang Biopharmaceuticals.
  • Nippon Boehringer Ingelheim Co., Ltd.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Strength
Market Snippet, By Indication
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Pipeline Analysis
Epidemiology
Historical Overview
Merger and Acquisition
Regulatory Scenario
PORTER’S Five Forces
PEST Analysis
4. Global Telmisartan Market, By Strength, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
20mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
40mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
80mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
5. Global Telmisartan Market, By Indication, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hypertension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Cardiac Arrest
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Stroke
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
6. Global Telmisartan Market, By Composition, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Single
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Combinational
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
7. Global Telmisartan Market, By Distribution Channel, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
8. Global Telmisartan Market, By Regions, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2016 – 2026
Regional Trends
North America
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Northern Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
9. Competitive Landscape
Heat Map Analysis
Company Profiles
C.H. Boehringer Sohn AG & Ko. KG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Glenmark Generics Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Torrent Pharmaceuticals Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Solco Healthcare U.S.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Mylan Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Aurobindo Pharma Limited
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Yichang Changjiang Pharmaceutical Co., Ltd
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Wanbang Biopharmaceuticals
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Nippon Boehringer Ingelheim Co., Ltd.
Company Overview.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Analyst Views
10. Section
References
Research Methodology
About us and Sales Contact
*Browse 23 market data tables and 19 figures on "Telmisartan Market” - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook